Business Description
Genomic Valley Biotech Ltd
ISIN : INE574D01010
Total Employee Number:
3Compare
Compare
Traded in other countries / regions
539206.India IPO Date
2015-07-10Description
Genomic Valley Biotech Ltd is an India-based biotechnology company operating in the fields of genomics, molecular diagnostics, and AI-driven healthcare. The Company provides Next-Generation Sequencing (NGS) based diagnostic services, oncology diagnostics, personalized healthcare solutions, genetic disease risk assessment, community genomic screening, and research process outsourcing services. Its business is mainly segmented into diagnostic services and research services, with a focus on genomics, bioinformatics, and AI-enabled data analysis. The Company operates mainly in India, while also serving international researchers and collaborators.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.92 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 16.89 | |||||
Beneish M-Score | -0.52 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -53.7 | |||||
3-Year EBITDA Growth Rate | -59.4 | |||||
3-Year EPS without NRI Growth Rate | -67.8 | |||||
3-Year FCF Growth Rate | 70.9 | |||||
3-Year Book Growth Rate | 3.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 64.63 | |||||
9-Day RSI | 54.39 | |||||
14-Day RSI | 51.75 | |||||
3-1 Month Momentum % | 25.81 | |||||
6-1 Month Momentum % | 11.54 | |||||
12-1 Month Momentum % | -37.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 8.41 | |||||
Quick Ratio | 7.53 | |||||
Cash Ratio | 0.08 | |||||
Days Sales Outstanding | 3068.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | 14.99 | |||||
Net Margin % | 11.33 | |||||
EBITDA Margin % | 16.37 | |||||
FCF Margin % | -7.1 | |||||
OCF Margin % | -7.1 | |||||
ROE % | 0.77 | |||||
ROA % | 0.7 | |||||
ROIC % | 0.71 | |||||
3-Year ROIIC % | -135.09 | |||||
ROC (Joel Greenblatt) % | 1.58 | |||||
ROCE % | 1.02 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 310.08 | |||||
PE Ratio without NRI | 310.08 | |||||
Shiller PE Ratio | 81.01 | |||||
PS Ratio | 34.74 | |||||
PB Ratio | 2.24 | |||||
Price-to-Tangible-Book | 2.28 | |||||
EV-to-EBIT | 220.24 | |||||
EV-to-EBITDA | 201.64 | |||||
EV-to-Revenue | 33.02 | |||||
EV-to-FCF | -452.77 | |||||
Price-to-GF-Value | 2.26 | |||||
Price-to-Graham-Number | 5.64 | |||||
| Price-to-Net-Current-Asset-Value | 3.76 | |||||
Earnings Yield (Greenblatt) % | 0.46 | |||||
FCF Yield % | -0.22 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genomic Valley Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 2.675 | ||
| EPS (TTM) (₹) | 0.093 | ||
| Beta | 0.9354 | ||
| 3-Year Sharpe Ratio | 0.34 | ||
| 3-Year Sortino Ratio | 0.59 | ||
| Volatility % | 42.22 | ||
| 14-Day RSI | 51.75 | ||
| 14-Day ATR (₹) | 1.15488 | ||
| 20-Day SMA (₹) | 28.864 | ||
| 12-1 Month Momentum % | -37.42 | ||
| 52-Week Range (₹) | 20.1 - 53.49 | ||
| Shares Outstanding (Mil) | 3.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genomic Valley Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genomic Valley Biotech Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genomic Valley Biotech Ltd Frequently Asked Questions
What is Genomic Valley Biotech Ltd(BOM:539206)'s stock price today?
The current price of BOM:539206 is ₹29.29. The 52 week high of BOM:539206 is ₹53.49 and 52 week low is ₹20.10.
When is next earnings date of Genomic Valley Biotech Ltd(BOM:539206)?
The next earnings date of Genomic Valley Biotech Ltd(BOM:539206) is .
Does Genomic Valley Biotech Ltd(BOM:539206) pay dividends? If so, how much?
Genomic Valley Biotech Ltd(BOM:539206) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Genomic Valley Biotech Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers